Pathway-level mutational signatures predict breast cancer outcomes and reveal therapeutic targets.

BACKGROUND AND PURPOSE: In order to significantly improve the therapeutic treatment of breast cancer, the exploration of underlying genetic and molecular differences is absolutely necessary. Here, our goal was to integrate mutational status of entire…

Preview only. Read the full abstract at the source